Related Experiment Video
Updated: Jan 17, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Effect of Hypothyroidism on Lipid Profile and Liver Enzymes: Implications In Non-Alcoholic Fatty Liver Disease
S V Hegde1, A S K Bhattam2, A Sequeira3
1Professor, Department of Biochemistry, Srinivas Institute of Medical Science and Research Centre, Mukka, Mangalore-574146, India.
Background:
Hypothyroidism is known to affect lipid metabolism, and its association with non-alcoholic fatty liver disease (NAFLD) is of growing interest. This study aimed to evaluate the effects of hypothyroidism on lipid profiles and liver enzymes, with a particular focus on the implications for NAFLD.
Methods:
A case-control study was conducted with 74 participants, including 44 hypothyroid patients (22 with overt hypothyroidism and 22 with subclinical hypothyroidism) and 30 healthy controls. Participants were aged 20-65 years, and a detailed clinical history was obtained to exclude comorbid conditions such as diabetes, liver disorders, alcohol consumption, and acute inflammatory diseases. Waist circumference, BMI, and blood pressure were measured, and venous blood samples were drawn for analysis. Thyroid hormones (TSH, T3, T4) were measured using enzyme-linked fluorescent assays, while lipid profile (cholesterol, triglycerides) and liver enzymes (ALT, AST, ALP) were assessed using an automated clinical analyzer. Statistical analysis included ANOVA, post-hoc tests, and correlation analysis.
Results:
Significant differences were observed in TSH levels between the groups (p < 0.001), with the overt hypothyroid group showing the highest mean TSH. BMI was higher in the hypothyroid groups compared to controls, but the difference was not statistically significant (p = 0.065). Cholesterol levels were significantly elevated in both the overt and subclinical hypothyroid groups (p = 0.032), with post-hoc analysis revealing significant differences between the overt hypothyroid group and controls (p = 0.016). No significant differences were found in triglyceride levels across groups (p = 0.191). Outlier analysis of TSH levels revealed several extreme values in the overt hypothyroid group, reflecting more severe thyroid dysfunction. Correlation analysis showed a weak positive correlation between TSH and BMI (r = 0.18, p = 0.044), while no significant correlations were observed between TSH and age, or BMI and age.
Conclusion:
Hypothyroidism, particularly overt hypothyroidism, is associated with altered lipid metabolism and higher cholesterol levels. These changes may contribute to an increased risk of NAFLD in individuals with thyroid dysfunction.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

